Skip to content

Guardant Health GH Price / sales

Price / sales at other companies

Illumina logo
IlluminaILMN
4.3×+1.4×
Natera, Inc. logo
Natera, Inc.NTRA
11.3×+0.9×
Quest Diagnostics logo
Quest DiagnosticsDGX
1.9×+0.1×
Agilent Technologies logo
Agilent TechnologiesA
4.5×-0.1×
Labcorp Holdings logo
Labcorp HoldingsLH
1.6×+0.1×
Abbott logo
AbbottABT
-1.5×

Other financials

Income statement

See full
Revenue$301.7M+48.3%
Gross profit$196.7M+52.8%
Operating income-$121.4M-9.3%
Net income-$112.1M-17.8%
EPS (diluted)-$0.85-10.4%

Balance sheet

See full
Cash & equivalents$1.1B+37.0%
Total debt$1.7B+30.5%
Total equity-$181.1M+27.8%
Total assets$1.9B+42.5%

Cash flow

See full
Operating cash flow-$65.6M-4.7%
CapEx$5.6M+25.1%
Free cash flow-$71.2M-6.0%

Valuation

See full
Market cap$17.12B+130%
Enterprise value$17.72B+121%

Profitability

See full
Gross margin64.9%+3.6pp
Operating margin-41.4%-9.4pp
Net margin-40.1%-8.1pp

Returns & leverage

See full
Return on equity-438.1%-1,655pp
Debt / equity
Current ratio4.7×+0.6×

Where this comes from

Calculated from Guardant Health’s reported figures.

Based on the most recent quarter.

The official record: Guardant Health’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Guardant Health's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Guardant Health's price / sales?
Guardant Health (GH) reported price / sales of 11.2× in Q1 2026.
How has Guardant Health's price / sales changed year-over-year?
Guardant Health's price / sales increased by 65.1% year-over-year, from 6.8× to 11.2×.
What is the long-term trend for Guardant Health's price / sales?
Over 4 years (2021 to 2025), Guardant Health's price / sales has grown at a -30.4% compound annual growth rate (CAGR), from 155.3× to 36.4×.
What does price / sales mean?
How many dollars investors pay for each dollar of the company's annual sales.
How do you interpret price / sales?
Useful when earnings are negative or volatile (e.g. early-stage or cyclical firms). Only comparable across companies with similar margins — a sales dollar is worth more at a high-margin business.
How does price / sales compare across companies?
Best compared within a margin cohort; a software P/S and a retailer P/S are not directly comparable.